Clinical significance of Wnt-induced secreted protein-1 (WISP-1/CCN4) in esophageal squamous cell carcinoma

Anticancer Research

Volumn 31, Issue 3, 2011, Pages 991-997

  Nagai, Yohei ^a   Watanabe, Masayuki ^a   Ishikawa, Shinji ^b   Karashima, Ryuichi ^a   Kurashige, Junji ^a   Iwagami, Shiro ^a   Iwatsuki, Masaaki ^a   Baba, Yoshihumi ^a   Imamura, Yu ^a   Hayashi, Naoko ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Department of Surgery   (Japan)

Author keywords

CCN family; Esophageal cancer; WISP 1; WISP 1v

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; UNCLASSIFIED DRUG; WNT INDUCED SECRETED PROTEIN 1; WNT PROTEIN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER INFILTRATION; CANCER INVASION; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSTHORACIC SUBTOTAL ESOPHAGECTOMY; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; SURVIVAL ANALYSIS;

EID: 79956072497     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Parkin DM, Pisani P and Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 827-841, 1999.
2. Pisani P, Parkin DM, Freddie B and Ferlay J: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83: 18-29, 1999.
3. Logan CY and Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810, 2004. (Pubitemid 39488658)
4. Mohammad I: Wnt signaling and the mechanistic basis of tumour development. J Pathol 205: 130-144, 2005.
5. Polakis P: Wnt signaling and cancer. Genes Dev 14: 1837-1851, 2000.
6. Clement G, Braunschweig R, Pasquier N et al: Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus. Oncogene 25: 3084-3092, 2006. (Pubitemid 43780474)
7. Zhang G, Zhou X, Xue L et al: Accumulation of cytoplasmic β-catenin correlates with reduced expression of E-cadherin, but not with phosphorylated Akt in esophageal squamous cell carcinoma: Immunohistochemical study. Pathol Int 55: 310-317, 2005. (Pubitemid 40910663)
8. Veeramachaneni NK, Kubokura H, Lin L et al: Down-regulation of beta catenin inhibits the growth of esophageal carcinoma cells. Thorac Cardiovasc Surg 127: 92-98, 2004. (Pubitemid 38160471)
9. Mizushima T, Nakagawa H, Kamberov YG et al: Wnt-1 but not epidermal growth factor induces β-catenin/T-cell factor-dependent transcription in esophageal cancer cells. Cancer Res 62: 277-282, 2002 (Pubitemid 34074015)
10. Castro J, Gamallo C, Palacios J et al: β-catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome. Virchows Arch 437: 599-604, 2000.
11. Ninomiya I, Endo Y, Fushida S et al: Alteration of β-catenin expression in esophageal squamous-cell carcinoma. Int J Cancer 85: 757-761, 2000. (Pubitemid 30131461)
12. Yang F, Zeng Q, Yu G et al: Wnt/β-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC. Cell Signal 18: 679-687, 2006. (Pubitemid 43113298)
13. Rhee CS, Sen M, Lu D et al: Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 21: 6598-6605, 2002. (Pubitemid 35177038)
14. Perbal B: CCN proteins: multifunctional signalling regulators. Lancet 363: 62-64, 2004.
15. Kubota S and Takigawa M: CCN family proteins and angiogenesis: from embryo to adulthood. Angiogenesis 10: 1-11, 2007. (Pubitemid 46356220)
16. Inkson CA, Ono M, Sergei A et al: TGF-β1 and WISP-1/CCN-4 can regulate each other's activity to cooperatively control osteoblast function. J Cell Biochem 104: 1865-1878, 2008.
17. Pennica D, Swanson TA, Welsh JW et al: WISP genes are members of the connective tissue growth factor family that are upregulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA 95: 14717-14722, 1998.
18. Xu L, Corcoran RB, Welsh JW et al: WISP-1 is a Wnt-1 and β-catenin-responsive oncogene. Genes Dev 14: 585-595, 2000.
19. Colston JT, De la Rosa SD, Koehler M et al: Wnt-induced secreted protein-1 is a prohypertrophic and profibrotic growth factor. Am J Physiol Heart Circ Physiol 293: 1839-1846, 2007.
20. Tanaka S, Sugimachi K, Saeki H et al: A novel variant of WISP-1 lacking a Von Willebrand type C module overexpressed in scirrhous gastric carcinoma. Oncogene 20: 5525-5532, 2001. (Pubitemid 32889489)
21. Desnoyers L, Arnott D, and Pennica D: WISP-1 binds to decorin and biglycan. J BIol Chem 276: 47599-47607, 2001.
22. French DM, Kaul RJ, D'Souza AL et al: WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair. Am J Pathol 165: 855-867, 2004. (Pubitemid 39129293)
23. Khor TO, Gul YA, Ithnin H et al: A comparative study of the expression of Wnt-1, WISP-1, surviving and cyclin-D1 in colorectal carcinoma. Int J Colorectal Dis 21: 291-300, 2006. (Pubitemid 43880533)
24. Tian C, Zhou ZG, Meng WJ et al: Overexpression of connective tissue growth factor WISP-1 in Chinese primary rectal cancer patients. World J Gastroenterol 13: 3878-3882, 2007. (Pubitemid 47272317)
25. Xie D, Nakachi K, Wang H et al: Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 61: 8917-8923, 2001.
26. Davies SR, Watkins G et al: Differential expression and prognostic implications of the CCN family members WISP-1, WISP-2, and WISP-3 in human breast cancer. Ann Surg Oncol 14: 1909-1918, 2007.
27. Tanaka S, Sugimachi K, Kameyama T et al: Human WISP-1v, a member of the CCN family, is associated with invasive cholangiocarcinoma. Hepatology 37: 1122-1129, 2003. (Pubitemid 36538689)
28. Soon LL, Yie TA, Shvarts A et al: Overexpression of WISP-1 down-regulated motility and invasion of lung cancer cells through inhibition of Rac activation. J Biol Chem 278: 11465-11470, 2003.
29. Deng YZ, Chen PP, Wang Y et al: Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through β-catenin-T-cell factor/Lef signaling. J Biol Chem 282: 36571-36581, 2007.
30. Baba H, Korenaga D, Haraguchi M et al: Width of serosal invasion and prognosis in advanced human gastric cancer with special reference to the mode of tumor invasion. Cancer 64: 2482-2486, 1989. (Pubitemid 20014929)
31. Nomiya T, Nemoto K, Miyachi H et al: Relationship between radiosensitivity and microvascular density in esophageal carcinoma: significance of hypoxic fraction. Int J Radiation Oncology Biol Phys 58: 589-596, 2004. (Pubitemid 38145594)
32. Lin MT, Kuo IH, Chang CC et al: Involvement of hypoxia-inducing factor-1α-dependent plasminogen activator inhibitor-1 up-regulation in Cys61/CCN1-induced gastric cancer cell invasion. J Biol Chem 283: 15807-15815, 2008.
33. Chintalapudi MR, Markiewicz M, Kose N et al: Cyr61/CCN1 and CTGF/CCN2 mediate the pro-angiogenic activity of VHL mutant renal carcinoma cells. Carcinogenesis 29: 696-703, 2008. (Pubitemid 351494156)
34. Su F, Overholtzer M, Besser D et al: WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. Genes Dev 16: 46-57, 2002. (Pubitemid 34049637)